![]() |
DISCLAIMER | PRIVACY |
Newswire | Forums | Books | About this site
|
Vitamin D, NSAIDS provide double whammy against prostate cancer, Stanford study http://www.psa-rising.com/med/chemo/vitD_NSAIDs05.html Celebrex and other NSAIDs Continue to Show Anti-Cancer Potential April 19, 2005 Use of aspirin or other NSAIDs increases survival for men with prostate cancer Celebrex attacks prostate cancer cells in ways Vioxx does not "These beneficial effects were observed at concentrations of celecoxib that occur in humans," added Dannenberg. "This increases the likelihood that our findings are clinically relevant." March 1, 2005 Cancer Patients and Celebrex in Anti-Cancer Trials Nov 10, 2004 Mayo researchers define celecoxib pathways and mechanisms for tumor reduction anti-inflammatory drug Celebrex , or celecoxib, reduces tumor mass ... Celebrex Cancer Trial Stopped After Heart Attacks Anti-Inflammatory Drug (Celebrex ) Effective for Recurrent Prostate Cancer Celebrex , Cancer Patients and the Vioxx Cover-Up FDA says Celebrex Heart Risk More Than Tripled FDA Advised to Let Celebrex Stay on Market, Call for Warning Labels Estrogen-associated COX-2 pathways explain protection from heart disease in... Potentially fatal toxicities occur with off-label use of cancer drugs
|
advertising |
|
General Disclaimer: PSA Rising is designed for informational purposes only and is not engaged in rendering medical advice or professional services. News and information provided through PSA Rising should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your healthcare provider. www. psa-rising.com © PSA Rising 1997-2005 |